Research
Hormonal
Childhood trauma, abuse, and neglect are strongly linked to the development of eating disorders, particularly Bulimia Nervosa and Binge Eating Disorder, through interactions with genetic susceptibility.
If you have experienced childhood trauma, you may be at higher risk for eating disorders. This risk is not inevitable, but it is significant. Trauma-informed therapy and support can help address the underlying emotional pain that may manifest as disordered eating.
GoodSupportsHIGH confidence
Abuse, trauma and childhood obesity are strongly linked to eating disorders... Exposure to childhood trauma has been linked to polymorphisms in genes expressed in the glucocorticoid receptor pathway which are associated with increased risk of developing BN, binge eating, and loss of control over eating
Why this rating
Supported by multiple studies including meta-analyses and longitudinal data.
Source
Risk factors for eating disorders: findings from a rapid review
Sarah Barakat et al. · Journal of Eating Disorders · 2023
DOI 10.1186/s40337-022-00717-4
narrative_reviewCited 311×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Genetic factors, particularly polymorphisms affecting neurotransmitter systems (dopamine, serotonin) and metabolic traits (BMI, insulin resistance), significantly increase the risk of developing eating disorders, with distinct genetic architectures for anorexia nervosa versus binge-type disorders.Good
- Gut microbiota dysbiosis, specifically involving Escherichia Coli producing the CIpB protein, may contribute to eating disorder pathology by mimicking satiety hormones and triggering autoimmune reactions.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →